Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$41.80
-0.38-0.90%
At close: -
$41.80
-0.001200.00%
After Hours: Jun 27, 4:10 PM EDT
Comments
Loading...
Bruker Analyst Ratings and Price Targets | NASDAQ:BRKR | Benzinga
Bruker Corp has a consensus price target of $62.79 based on the ratings of 16 analysts. The high is $102 issued by UBS on March 1, 2024. The low is $40 issued by Citigroup on May 22, 2025. The 3 most-recent analyst ratings were released by B of A Securities, Citigroup, and UBS on June 26, 2025, May 22, 2025, and May 8, 2025, respectively. With an average price target of $45 between B of A Securities, Citigroup, and UBS, there's an implied 7.66% upside for Bruker Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
B of A Securities
Citigroup
UBS
Barclays
Goldman Sachs
1calculated from analyst ratings
Analyst Ratings for Bruker
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/26/2025 | Buy Now | 19.62% | B of A Securities | Derik De Bruin84% | $61 → $50 | Maintains | Buy | Get Alert |
| 05/22/2025 | Buy Now | -4.3% | Citigroup | Patrick Donnelly80% | $50 → $40 | Downgrade | Buy → Neutral | Get Alert |
| 05/08/2025 | Buy Now | 7.66% | UBS | Dan Leonard55% | $57 → $45 | Maintains | Neutral | Get Alert |
| 05/08/2025 | Buy Now | 10.05% | Barclays | Luke Sergott52% | $50 → $46 | Maintains | Overweight | Get Alert |
| 05/08/2025 | Buy Now | 7.66% | Goldman Sachs | Matthew Sykes64% | $50 → $45 | Maintains | Neutral | Get Alert |
| 05/08/2025 | Buy Now | 14.84% | Stifel | Daniel Arias78% | $57 → $48 | Maintains | Hold | Get Alert |
| 04/17/2025 | Buy Now | 43.54% | Wells Fargo | Brandon Couillard69% | $75 → $60 | Maintains | Overweight | Get Alert |
| 04/10/2025 | Buy Now | 19.62% | Barclays | Luke Sergott52% | $60 → $50 | Maintains | Overweight | Get Alert |
| 04/07/2025 | Buy Now | 19.62% | Citigroup | Patrick Donnelly80% | $75 → $50 | Maintains | Buy | Get Alert |
| 02/24/2025 | Buy Now | — | Guggenheim | Subbu Nambi46% | — | Reiterates | Buy → Buy | Get Alert |
| 02/14/2025 | Buy Now | 36.37% | Stifel | Daniel Arias78% | $70 → $57 | Maintains | Hold | Get Alert |
| 02/14/2025 | Buy Now | 43.54% | Barclays | Luke Sergott52% | $65 → $60 | Maintains | Overweight | Get Alert |
| 02/10/2025 | Buy Now | 55.51% | Barclays | Luke Sergott52% | $69 → $65 | Maintains | Overweight | Get Alert |
| 01/17/2025 | Buy Now | — | Guggenheim | Subbu Nambi46% | — | Reiterates | Buy → Buy | Get Alert |
| 12/19/2024 | Buy Now | 72.25% | Guggenheim | Subbu Nambi46% | → $72 | Initiates | → Buy | Get Alert |
| 12/13/2024 | Buy Now | 91.39% | B of A Securities | Derik De Bruin84% | $78 → $80 | Maintains | Buy | Get Alert |
| 12/10/2024 | Buy Now | 57.9% | UBS | Dan Leonard55% | $102 → $66 | Assumes | Buy → Neutral | Get Alert |
| 12/05/2024 | Buy Now | 43.54% | Goldman Sachs | Matthew Sykes64% | $60 → $60 | Upgrade | Sell → Neutral | Get Alert |
| 11/06/2024 | Buy Now | 79.43% | Citigroup | Patrick Donnelly80% | $80 → $75 | Maintains | Buy | Get Alert |
| 11/06/2024 | Buy Now | 67.47% | TD Cowen | Dan Brennan64% | $72 → $70 | Maintains | Hold | Get Alert |
| 11/06/2024 | Buy Now | 79.43% | Wells Fargo | Brandon Couillard69% | $78 → $75 | Maintains | Overweight | Get Alert |
| 11/06/2024 | Buy Now | 65.08% | Barclays | Terence Malone51% | $75 → $69 | Maintains | Overweight | Get Alert |
| 10/15/2024 | Buy Now | 79.43% | Barclays | Terence Malone51% | → $75 | Initiates | → Overweight | Get Alert |
| 09/30/2024 | Buy Now | — | Wolfe Research | Doug Schenkel72% | — | Downgrade | Outperform → Peer Perform | Get Alert |
| 08/27/2024 | Buy Now | 86.61% | Wells Fargo | Brandon Couillard69% | → $78 | Initiates | → Overweight | Get Alert |
| 08/07/2024 | Buy Now | 72.25% | TD Cowen | Max Masucci27% | $74 → $72 | Maintains | Hold | Get Alert |
| 07/10/2024 | Buy Now | 91.39% | Citigroup | Patrick Donnelly80% | $95 → $80 | Maintains | Buy | Get Alert |
| 07/09/2024 | Buy Now | 43.54% | Goldman Sachs | Matthew Sykes64% | $72 → $60 | Maintains | Sell | Get Alert |
| 05/20/2024 | Buy Now | 84.22% | Stifel | Daniel Arias78% | $81 → $77 | Maintains | Hold | Get Alert |
| 05/20/2024 | Buy Now | 115.32% | B of A Securities | Derik De Bruin84% | $95 → $90 | Maintains | Buy | Get Alert |
| 04/10/2024 | Buy Now | 77.04% | Goldman Sachs | Matthew Sykes64% | $66 → $74 | Maintains | Sell | Get Alert |
| 03/01/2024 | Buy Now | 144.03% | UBS | John Sourbeer34% | $94 → $102 | Maintains | Buy | Get Alert |
| 02/15/2024 | Buy Now | 124.89% | UBS | John Sourbeer34% | $86 → $94 | Maintains | Buy | Get Alert |
| 02/14/2024 | Buy Now | 115.32% | JP Morgan | Rachel Vatnsdal66% | $60 → $90 | Upgrade | Neutral → Overweight | Get Alert |
| 02/14/2024 | Buy Now | 127.28% | Citigroup | Patrick Donnelly80% | $80 → $95 | Maintains | Buy | Get Alert |
| 02/14/2024 | Buy Now | 93.79% | Stifel | Daniel Arias78% | $63 → $81 | Maintains | Hold | Get Alert |
| 12/19/2023 | Buy Now | 72.25% | Wells Fargo | Timothy Daley53% | → $72 | Initiates | → Equal-Weight | Get Alert |
| 12/13/2023 | Buy Now | — | Wolfe Research | Doug Schenkel72% | — | Initiates | → Outperform | Get Alert |
| 10/17/2023 | Buy Now | 55.51% | JP Morgan | Rachel Vatnsdal66% | $70 → $65 | Maintains | Neutral | Get Alert |
| 05/05/2023 | Buy Now | 127.28% | Citigroup | Patrick Donnelly80% | $90 → $95 | Maintains | Buy | Get Alert |
| 04/19/2023 | Buy Now | 67.47% | Goldman Sachs | Matthew Sykes64% | $63 → $70 | Maintains | Sell | Get Alert |
| 04/18/2023 | Buy Now | 67.47% | Goldman Sachs | — | $63 → $70 | Maintains | Sell | Get Alert |
| 02/10/2023 | Buy Now | 115.32% | Citigroup | Patrick Donnelly80% | $80 → $90 | Maintains | Buy | Get Alert |
| 10/21/2022 | Buy Now | 67.47% | UBS | John Sourbeer34% | → $70 | Initiates | → Buy | Get Alert |
| 08/22/2022 | Buy Now | 91.39% | Citigroup | Patrick Donnelly80% | $70 → $80 | Upgrade | Neutral → Buy | Get Alert |
FAQ
What is the target price for Bruker (BRKR) stock?
The latest price target for Bruker (NASDAQ:BRKR) was reported by B of A Securities on June 26, 2025. The analyst firm set a price target for $50.00 expecting BRKR to rise to within 12 months (a possible 19.62% upside). 28 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Bruker (BRKR)?
The latest analyst rating for Bruker (NASDAQ:BRKR) was provided by B of A Securities, and Bruker maintained their buy rating.
When was the last upgrade for Bruker (BRKR)?
The last upgrade for Bruker Corp happened on December 5, 2024 when Goldman Sachs raised their price target to $60. Goldman Sachs previously had a sell for Bruker Corp.
When was the last downgrade for Bruker (BRKR)?
The last downgrade for Bruker Corp happened on May 22, 2025 when Citigroup changed their price target from $50 to $40 for Bruker Corp.
When is the next analyst rating going to be posted or updated for Bruker (BRKR)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Bruker, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Bruker was filed on June 26, 2025 so you should expect the next rating to be made available sometime around June 26, 2026.
Is the Analyst Rating Bruker (BRKR) correct?
While ratings are subjective and will change, the latest Bruker (BRKR) rating was a maintained with a price target of $61.00 to $50.00. The current price Bruker (BRKR) is trading at is $41.80, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
